CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Processa Pharmaceuticals, Inc.

PCSA
$5MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for PCSA. That does not mean none is planned.

Get an email about PCSA's next catalysts

Track Processa Pharmaceuticals (PCSA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

1 upcoming event in our data (earnings).See the timeline

Catalyst Timeline

1 upcoming, 0 past

Earnings

PCSA Earnings Report

November 2026~

Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaVERO BEACH10 employees
Drug Pipeline

Frequently asked questions

What is in Processa Pharmaceuticals, Inc.'s drug pipeline?β†’

CatalystAlert tracks 4 drug candidates in Processa Pharmaceuticals, Inc.'s (PCSA) pipeline across Phase 2. Its lead program is PCS12852 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Processa Pharmaceuticals, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Processa Pharmaceuticals, Inc. (PCSA) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track PCSA biotech catalysts?β†’

Add PCSA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Processa Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply